MIT to drop affiliation with Central Coast Enterprise Forum
The Massachusetts Institute of Technology Enterprise Forum Global will be closing its program effective June 30 and is asking all of its affiliated chapters, including the Central Coast chapter, to discontinue all association with the brand. The news came in an April 30 email to Enterprise Forum chapters from the CEO of MIT Technology Review, Read More →
Read More →Arcutis shares down after earnings report
Westlake Village-based Arcutis Biotherapeutics suffered a net loss in the first quarter of fiscal year 2021, but continues to hold a strong financial position with $446.5 million in assets. According to earnings released May 4, Arcutis lost $36 million in the first quarter, or 76 cents per share, compared to a loss of $28 million, Read More →
Read More →Atara beats estimates with loss in Q1
Atara Biotherapeutics had a net loss of $78.2 million in the first quarter of fiscal year 2021, slightly higher compared than same quarter a year earlier, when the company had a loss of $73.5 million. Despite this, Atara, an immunotherapy biotech company based in South San Francisco with some of its major operations in Thousand Read More →
Read More →Fienup: A long road to get economy out of ‘crisis mode’
Ventura County’s economy was in a rougher place than previously understood when the pandemic started, and rebuilding it in a way that benefits everyone is going to take a lot of careful work. That was the message from Matthew Fienup, the executive director of the Center for Economic Research and Forecasting at California Lutheran University, Read More →
Read More →LTC Properties reports income drop
LTC Properties saw its net income drop almost 80% in a year as it missed estimates and saw decreased rental income. The Westlake Village-based real estate investment trust, which specializes in health care and senior living properties, reported $13.6 million in net income, or 35 cents per diluted share, for the first quarter of 2021. Read More →
Read More →Thousand Oaks biotech firm closes $140M funding round
Capsida Biotherapeutics, a biotechnology startup based in Thousand Oaks, announced April 29 that it is emerging from “stealth mode” with a $140 million funding round led by Westlake Village BioPartners and Versant Ventures. The Series A round includes $50 million from Westlake Village BioPartners, a venture capital firm in Thousand Oaks focused on biotech startups Read More →
Read More →Teledyne shares up on earnings news as Flir acquisition draws nearer
Teledyne Technologies saw growth in nearly all markets during the first quarter of 2021, helping the company beat expectations and deliver positive results on its first earnings report of the year. Teledyne, a Thousand Oaks-based industrial and scientific conglomerate, reported an adjusted earnings per share of $3.02 for the first quarter of 2021, beating Zacks’ Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
